CureMark preparing for the submission of treatment for autism: enzyme replacement therapy

researchCureMark, a New York based company has raised $18.5 million to aid its preparation for a new treatment that they believe will answer some of the problems regarding autism. Claiming to be the pioneer in researching and testing of the condition’s underlying physiology, CureMark posits that one of the major elements that comprise autism is a malfunctioning digestive process. It says that when the body fails to digest certain proteins, the production of amino acid is thereby affected. Consequently, the brain of that person also malfunctions.

CM-AT is one of the Fast Track drugs recognized by the U.S. Food and Drug Administration (FDA) back in 2010. Fast Track drugs are meant to cure serious medical conditions that still have gaps to fill. Since CureMark’s potential treatment is CM-AT, the U.S. FDA’s review process will move forward faster.

Through a series of tests, primary and secondary endpoints in the whole study were met. Children aged three to eight who were battling with autism were crucial to the study. CureMark has finished the Phase 3 of CM-AT trial.

Due to the promise CureMark’s recent advancement brings, Kimball Duncan, Allan Johnston and other investors have shown support for the project. Chief Executive Officer of CureMark, Dr. Joan Fallon, along with several other women entrepreneurs last June, had a dialogue with the White House. They were asking the government to lead the investments in life science companies that are just starting. Fallon suggested that the White House give what she calls a Federal Life Sciences Startup Package that will aid these emerging life science companies in research, development, and intellectual property protection costs.

Aside from CureMark, there are 380 clinical trials for autism. There are also companies that believe in early treatment of autism as the best time for treatment like SynapDx. However, there are also documented cases of failed clinical trials such as Seaside which just this year claimed to have pioneered the treatment for social deficiencies.

Originally posted 2013-10-15 10:41:26.

Top Stories and Breaking News

Researchers hope to revolutionize autism diagnosis through Autism & Beyond app

New York — A team of researchers from Duke are hoping to revolutionize how autism is diagnosed in young children through an iPhone app called ‘Autism & Beyond’. The researchers are working closely with Apple in hopes of improving how autism is diagnosed in children today. Due to the surge of the number of children […]

Autism book nominated for Samuel Johnson Prize

London — Steve Silberman’s “Neurotribes”, a book that explores autism, has been nominated for a Samuel Johnson Prize.  Autism Daily Newscast book review can be read here. The Samuel Johnson Prize is the leading literary award-giving body in the U.K. It recognizes non-fiction books written in the English language, and has been named after essayist […]

Children with autism in minorities face more hurdles than their peers

Rochester, N.Y. — Families caring for children with autism in minorities face more hurdles than other families who are going through the same challenges. The Center for Disease Control and Prevention (CDC) said that children of minorities often get a diagnosis much later than their Caucasian peers. According to the center, children of color are […]

News In Brief About News In Brief

These are short news articles that report quickly on breaking events or snapshots of news for quick coverage. They are not as in-depth but a synopsis.